moxonidine has been researched along with Atrial Fibrillation in 2 studies
moxonidine: structure given in first source
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with moxonidine is associated with less AF recurrences after ablation treatment for drug-refractory AF in patients with hypertension." | 5.19 | Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: a randomized, controlled study. ( Deftereos, S; Doudoumis, K; Efremidis, M; Giannopoulos, G; Katsivas, A; Kossyvakis, C; Letsas, K; Manolis, AS; Panagopoulou, V; Pyrgakis, V; Raisakis, K; Rentoukas, I; Stefanadis, C; Tousoulis, D, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deftereos, S | 2 |
| Giannopoulos, G | 2 |
| Kossyvakis, C | 2 |
| Efremidis, M | 2 |
| Panagopoulou, V | 2 |
| Raisakis, K | 2 |
| Kaoukis, A | 1 |
| Karageorgiou, S | 1 |
| Bouras, G | 1 |
| Katsivas, A | 2 |
| Pyrgakis, V | 2 |
| Stefanadis, C | 2 |
| Doudoumis, K | 1 |
| Letsas, K | 1 |
| Rentoukas, I | 1 |
| Manolis, AS | 1 |
| Tousoulis, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacologic Suppression of Central Sympathetic Activity for Prevention of Atrial Fibrillation Recurrence After Pulmonary Vein Isolation (MOXAF)[NCT01791699] | Phase 4 | 150 participants (Anticipated) | Interventional | 2012-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for moxonidine and Atrial Fibrillation
| Article | Year |
|---|---|
Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Convert | 2013 |
Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: a randomized, controlled study.
Topics: Aged; Antihypertensive Agents; Atrial Fibrillation; Catheter Ablation; Double-Blind Method; Female; | 2014 |